Nuss, Emily E.Hoffman, Matthew K.Goudar, Shivaprasad S.Kavi, AvinashMetgud, MrityunjaySomannavar, ManjunathOkitawutshu, JeanLokangaka, AdrienTshefu, AntoinetteBauserman, MelissaTembo, Abigail MwapuleChomba, ElwynCarlo, Waldemar A.Figueroa, LesterKrebs, Nancy F.Jessani, SaleemSaleem, SarahGoldenberg, Robert L.Kurhe, KunalDas, PrabirHibberd, Patricia L.Achieng, EmmahNyongesa, PaulEsamai, FabianLiechty, Edward A.Bucher, SherriGoco, NormanHemingway-Foday, JenniferMoore, JanetMcClure, Elizabeth M.Silver, Robert M.Derman, Richard J.Patel, ArchanaAspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group2024-09-092024-09-092024Nuss EE, Hoffman MK, Goudar SS, et al. Corrigendum to The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 10, October 2023, 101095. Am J Obstet Gynecol MFM. 2024;6(4):101309. doi:10.1016/j.ajogmf.2024.101309https://hdl.handle.net/1805/43215The authors regret that the originally published manuscript erroneously excluded a contributing author Archana Patel MD, PhD. The authors would like to apologise for any inconvenience caused.en-USPublisher PolicyAspirinLow-dose aspirinPreeclampsiaPreterm birthUSPSTFArticle